Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Healthcare Shares
Cochlear shares jump 6% on guidance upgrade
Healthcare Shares
Why is the Cochlear share price tumbling 5% on Tuesday?
52-Week Highs
6 ASX 200 stocks starting the year on 52-week highs
Record Highs
These 5 top ASX 200 shares are smashing new all-time highs today
Healthcare Shares
What is the outlook for ASX healthcare shares in 2024?
Share Market News
Why these 4 leading ASX 200 shares grabbed the Motley Fool's headlines this week
Record Highs
These 2 leading ASX 200 stocks are smashing all-time record highs today
Share Gainers
Here are the top 10 ASX 200 shares today
Dividend Investing
Which ASX 200 healthcare share will pay the best dividend yield in FY24?
Opinions
2 moves I'll make if the stock market plummets tomorrow
Blue Chip Shares
Analysts say these world-class ASX 200 blue-chip shares are buys
Healthcare Shares
Buy and hold this ASX 200 share which is a long term market leader: broker
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
